Evidence map›Paper›PMID 30113522›Full record

Trial reportMedicine and science in sports and exercise2019

Equivalent Hypertrophy and Strength Gains in β-Hydroxy-β-Methylbutyrate- or Leucine-supplemented Men.

Josephine S Jakubowski, Edwin P T Wong, Everson A Nunes, Kenneth S Noguchi, Joshua K Vandeweerd, Kevin T Murphy, Robert W Morton, Chris McGlory, Stuart M Phillips

Erratum issued Registry-linked trialOpen access · bronzeAbstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Medicine and science in sports and exercise, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04588103 (The Effects of 8 Weeks of Lower Limb Heat Therapy, Moderate-intensity Cycling Exercise, or Both on Vascular Function in Young, Healthy Males and Females), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04588103 nacompletednot on this mapstarted 2021, after this paper: background citation

The Effects of 8 Weeks of Lower Limb Heat Therapy, Moderate-intensity Cycling Exercise, or Both on Vascular Function in Young, Healthy Males and Females

TypeinterventionalSponsorMcMaster UniversityRan2021 to 2022Enrolled60ConditionsEndothelial DysfunctionArmsHeat therapy, Exercise training
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Frontiers in nutrition · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB).Journal of the International Society of Sports Nutrition · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Corrigendum.Medicine and science in sports and exercise · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. The Effects of Calcium-Oxidative medicine and cellular longevity · 2020
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Josephine S JakubowskiDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Edwin P T WongDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Everson A NunesDepartment of Physiological Sciences, Federal University of Santa Catarina, Florianopólis, BRAZIL.
Kenneth S NoguchiDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Joshua K VandeweerdDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Kevin T MurphyDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Robert W MortonDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Chris McGloryDepartment of Kinesiology, McMaster University, Ontario, CANADA.
Stuart M PhillipsDepartment of Kinesiology, McMaster University, Ontario, CANADA.
McMaster University · CAUniversidade Federal de Santa Catarina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ingestion of proteins with high leucine content during resistance training (RT) can augment hypertrophy. Some data suggest that a leucine metabolite, β-hydroxy, β-methylbutyrate (HMB), is substantially more anabolically efficacious than leucine. PURPOSE: We aimed to test whether supplementation with HMB versus leucine, added to whey protein, would result in differential muscle hypertrophy and strength gains in young men performing RT.

methodsTwenty-six resistance-trained men (23 ± 2 yr) performed 12 wk of RT with three phases. Phase 1: 8 wk of periodized RT (three training sessions per week). Phase 2: 2 wk overreaching period (five sessions per week). Phase 3: 2 wk taper (three sessions per week). Participants were randomly assigned to twice daily ingestion of: whey protein (25 g) plus HMB (1.5 g) (whey+HMB; n = 13) or whey protein (25 g) plus leucine (1.5 g) (whey+leu; n = 13). Skeletal muscle biopsies were performed before and after RT. Measures of fat- and bone-free mass, vastus lateralis (VL) muscle thickness and muscle cross-sectional area (CSA) (both by ultrasound), muscle fiber CSA, and 1-repetition maximum (1-RM) strength tests were determined.

resultsWe observed increases in fat- and bone-free mass, VL muscle thickness, muscle CSA and fiber type CSA and 1-RM strength with no differences between groups at any phase. We observed no differences between groups or time-group interactions in hormone concentrations at any phase of the RT program.

conclusionsβ-Hydroxy-β-methylbutyrate added to whey did not result in greater increases in any measure of muscle mass, strength, or hormonal concentration compared to leucine added to whey. Our results show that HMB is no more effective in stimulating RT-induced hypertrophy and strength gains than leucine.

Indexed as

Dietary SupplementsResistance TrainingAdultBiopsyBody CompositionCreatine KinaseDouble-Blind MethodHuman Growth HormoneHumansHydrocortisoneInsulin-Like Growth Factor ILeucineMaleMuscle, SkeletalMuscle StrengthPerformance-Enhancing Substancesbeta-hydroxyisovaleric acidCreatine KinaseHuman Growth HormoneHydrocortisoneIGF1 protein, humanInsulin-Like Growth Factor ILeucinePerformance-Enhancing SubstancesTestosteroneValerates

Identifiers

PMID30113522
PMCPMC6303132
OpenAlexW2886295818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.